Oncolytics Biotech (ONCY) Operating Expenses (2009 - 2026)
Oncolytics Biotech (ONCY) recorded Operating Expenses of $9.38 million in Q2 2026, up 101.7% from $4.65 million a year earlier.
Oncolytics Biotech (ONCY) Operating Expenses (2009 - 2026) Analysis & Trends
On a TTM basis, Oncolytics Biotech's Operating Expenses came in at $37.39 million as of Jun 30, 2026, up 63.8% year-over-year; for FY2025, it came in at $28.73 million, up 12.5% from FY2024.
- Annual Operating Expenses has increased for three straight years, with a five-year compound annual growth rate of 25.2% (FY2020 to FY2025).
- Across earlier years, Operating Expenses came in at $25.54 million in FY2024 (+2.0%), $25.04 million in FY2023 (+183.3%), $8.84 million in FY2022 (-16.8%) and $10.62 million in FY2021 (+13.7%).
- Quarterly Operating Expenses has ranged from $4.65 million in Q3 2022 to $13.3 million in Q4 2025 over the past five years.
- On a year-over-year basis, Operating Expenses rose in three of the last seven quarters, with growth averaging 28.2%.
- Peak year-over-year performance for Operating Expenses in the last five years was growth of 128.5% in Q1 2022, against a decline of 24.7% in Q1 2025 at the low end.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.95 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 10.12 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 10.56 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 6.09 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 9.70 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 6.54 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 18.20 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 6.68 Bn |
| 10 | Oncolytics Biotech | 60.94 Mn | 32.05 Mn | - | 9.38 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.38 Mn |
| Sep 30, 2025 | 10.07 Mn |
| Jun 30, 2025 | 4.65 Mn |
| Mar 31, 2025 | 4.88 Mn |
| Dec 31, 2024 | 6.04 Mn |
| Sep 30, 2024 | 7.28 Mn |
| Jun 30, 2024 | 5.79 Mn |
| Mar 31, 2024 | 6.48 Mn |
| Dec 31, 2023 | 6.50 Mn |
| Sep 30, 2023 | 8.24 Mn |
| Jun 30, 2023 | 5.33 Mn |
| Mar 31, 2023 | 4.98 Mn |
| Dec 31, 2022 | 6.27 Mn |
| Sep 30, 2022 | 4.65 Mn |
| Jun 30, 2022 | 2.23 Mn |
| Mar 31, 2022 | 2.05 Mn |
| Dec 31, 2021 | 3.00 Mn |
| Sep 30, 2021 | 2.28 Mn |
| Jun 30, 2021 | 2.86 Mn |
| Mar 31, 2021 | 2.48 Mn |
Oncolytics Biotech Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=ONCY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "ONCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=ONCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();